bevacizumab
roche
['cairo5', 'lba3506']
#cairo5 study results. #folfoxiri-b vs folfox/folfiri-b significantly increased pfs, orr and r0/1 resections at the cost of increased toxicity in pts with initially unresectable crlm and r-sided and/or ras/brafv600e mutated primary tumour lba3506
#meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB